Material for treatment of cerebral infarction and brain tissue regeneration method
Inactive Publication Date: 2011-07-21
NAT CENT FOR GERIATRICS & GERONTOLOGY
View PDF0 Cites 20 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Benefits of technology
[0034]A material for treatment of cerebral infarction and a brain tissue regeneration method according to the present invention are an unprecedented, original, and novel material for treatment of cerebral infarction and brain tissue regeneration method. The material for treatment of cerebral infarction and the brain tissue regenerati
Problems solved by technology
However, the rtPa intravenous drip treatment has the disadvantage that it is used in only approximately 2% of cases due to adverse reactions of intracerebral hemorrhage.
However, under the present ci
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0110]This Example shows nerve regeneration by porcine dental pulp tissue-derived CD31− / CD146− SP transplantation into rats after cerebral infarction.
[0111]Middle cerebral artery occlusion was performed using SD (Sprague-Dawley) rats to prepare rat models of cerebral infarction.
[0112]CD31-negative SP cells were fluorescently labeled with DiI and then transplanted 24 hours after cerebral infarction into an injection site Pi of the brain striatum in the brain tissues, as shown in FIGS. 1A and 1B, A PBS-injected control was used.
[0113]In FIG. 1A, B represents bregma, which is a point of intersection of the sagittal suture with the coronal suture of the cranium. L1 represents 6.0 mm, and L2 represents 1.0 mm.
[0114]FIG. 1B is a macro image of a coronal section. L3 represents 5.0 mm, and L4 represents 6.0 mm. ML represents a midline.
[0115]On day 21 after cell transplantation, perfusion fixation was performed, and frozen sections were prepared according to a routine method and immunostaine...
example 2
[0144]Unlike Example 1, human dental pulp tissue-derived dental pulp cells are used in this Example. Table 1 shows the properties of human dental pulp tissue-derived CD31− SP cells and porcine dental pulp tissue-derived CD31− SP cells.
[0145]As shown in Table 1, the human dental pulp tissue-derived CD31−SP cells highly expressed CD90 and CD150 compared with porcine dental pulp tissue-derived CD3 V SP cells, in flow cytometry. Moreover, the human dental pulp tissue-derived CD31−SP cells highly expressed CD105 compared with human total dental pulp cells.
[0146]This Example shows nerve regeneration by the cell transplantation of human dental pulp tissue-derived CD31− / CD146− SP cells and human dental pulp tissue-deriv...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
Disclosed is a therapeutic material for cerebral infarction, which can recover a vascular disorder in an area affected by cerebral infarction to improve the brain function. The therapeutic material for cerebral infarction includes a dental pulp stem cell comprising at least one member selected from a CD105-positive cell, an SP cell, a CD24-positive cell, a CD133-positive cell, a CD271-positive cell and a CD150-positive cell. The therapeutic material may additionally include a protein secreted from a dental pulp cell. A transplanted dental pulp stem cell cannot be differentiated directly into a neural progenitor cell or a neurocyte, but is involved indirectly in the promotion of differentiation to eliminate an area affected by cerebral infarction, thereby recovering the affected area into a normal area.
Description
TECHNICAL FIELD[0001]The present invention relates to a material for treatment of cerebral infarction and to a brain tissue regeneration method using the material for treatment of cerebral infarction.BACKGROUND ART[0002]Cerebral angiopathy is the second leading cause of death in Japan and is responsible for the greatest cause of being bed-ridden, while not causing death. Therefore, the aging society is in urgent need of development of therapy appropriate for cerebral angiopathy.[0003]Among cerebral angiopathies, ischemic cerebrovascular disease such as cerebral infarction or cerebral thrombosis occurs with the highest frequency. Mortality due to cerebral infarction is greater than the total mortality due to myocardial infarction and ischemic heart disease.[0004]If the cause of paralysis is cerebral infarction, current treatment is thought to be effective within 3 hours after development, at present.[0005]In addition, rtPa (recombinant tissue plasminogen activator) intravenous drip t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more